Related references
Note: Only part of the references are listed.Tanshinone II A attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression
Z. H. Ren et al.
PHYTOMEDICINE (2010)
Inhibition of warfarin hydroxylation by major tanshinones of Danshen (Salvia miltiorrhiza) in the rat in vitro and in vivo
Windy W. P. Wu et al.
PHYTOMEDICINE (2010)
Tanshinone IIA elicited vasodilation in rat coronary arteriole: Roles of nitric oxide and potassium channels
Guo-bao Wu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Advancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen)
Yong-Guo Li et al.
JOURNAL OF CHROMATOGRAPHY A (2009)
Ethnic variation in hypertension prevalence of women in Taiwan
T-C Su et al.
JOURNAL OF HUMAN HYPERTENSION (2009)
Danshen Extracts Decrease Blood C Reactive Protein and Prevent Ischemic Stroke Recurrence: A Controlled Pilot Study
Gelin Xu et al.
PHYTOTHERAPY RESEARCH (2009)
Activation of high conductance Ca2+-activated K+ channels by sodium tanshinoneII-A sulfonate (DS-201) in porcine coronary artery smooth muscle cells
Yan Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Vasorelaxant effect of isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate, a novel metabolite from Salvia miltiorrhiza, on isolated rat mesenteric artery
Sheng-Peng Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Cardiovascular effects of Danshen
Tsung O. Cheng
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress
Futian Tang et al.
VASCULAR PHARMACOLOGY (2007)
2007 guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2007)
Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension
David D. Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors
William B. Campbell et al.
HYPERTENSION (2007)
Sodium tanshinone IIA sulfonate depresses angiotensin II-induced cardiomyocyte hypertrophy through MEK/ERK pathway
Le Yang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
Blood pressure control in a diabetic population assessed by computer review
A. Swislocki et al.
JOURNAL OF HUMAN HYPERTENSION (2006)
Physiological roles of ATP-sensitive K+ channels in smooth muscle
Noriyoshi Teramoto
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Pharmacological evidence for calcium channel inhibition by Danshen (Salvia miltiorrhiza) on rat isolated femoral artery
FFY Lam et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use
LM Zhou et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction
AA Izzo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2005)
Hypertension treatment and control in five European Countries, Canada, and the United States
K Wolf-Maier et al.
HYPERTENSION (2004)
Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo
AM Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Hypertension in elderly persons: Its prevalence and associated cardiovascular risk factors in Tainan City, southern Taiwan
FH Lu et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2000)
Share Paper
